IL2 and melanoma: These results demonstrate that culturing splenocytes and DLN lymphocytes for AIT with IL-7/15/21 results in a much higher yield of cells with equal or greater activity against melanoma metastases than those cultured in either IL-2 (the current standard cytokine for expansion) or even the combination of IL-7+15.